Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
DIA 2021 Global Annual Meeting
Optimizing Cell and Gene Therapy Clinical Trial Virtualization and Remote Monitoring in the Time of COVID-19
Session Chair(s)

Monica Ravindra Shah, DrMed, FACC
- Therapeutic Science and Strategy Unit Vice President and Head, CAGT COE
- IQVIA, United States
Using virtual-hybrid and remote solutions, we describe an innovative model for monitoring and executing cell and gene therapy clinical trials during COVID-19. These approaches serve as an instructive path forward for the future of these therapies.
Learning Objective : Describe evolving strategies with innovative solutions for delivering cell and gene therapy trials during COVID-19; Discuss specific areas of trial risk, patient safety, data quality, and how virtual and remote activities are being successfully deployed; Analyze metrics to date and how these support a paradigm shift in the operation of these trials.
Speaker(s)
Industry Update
Chris Ashby Learn, PhD, PMP
- Senior Director, Clinical Development
- Istari Oncology, United States

Industry Update
Erin Finot, MBA, MS
- Vice President, Immuno-Oncology
- IQVIA, United States

Industry Update
Molly Mjolsness, MBA
- Senior Client Delivery Manager
- Be The Match Biotherapies, United States